The 3 Things That Matter Most for MercadoLibre Right Now

The credit portfolio grew 90% YoY to $12.5B in outstanding balances with ~3M new credit cards in Q4 and NPLs at 4.4%, but rising funding costs and a declining net interest margin elevate downside risk. Operating margin compressed ~300 bps YoY as management is investing aggressively (e.g., lower free-shipping threshold, scaling card operations) and is prioritizing growth over short-term profitability. Mexico shows strong growth potential — GMV +35% YoY (from 28%), items sold +45% YoY, fintech acquiring volume +50% YoY — but execution and credit-quality outcomes will determine whether the recent ~35% drop from the 52-week high is a buying opportunity.

Analysis

Treat MercadoLibre’s credit arm as a levered product innovation: moving mix toward unsecured, revolving instruments amplifies both earnings upside and tail volatility because loss-given-default and early charge-off behavior are less predictable than installment loans. The more the business leans on credit as a growth vector, the more it will internalize funding-market swings — expect day-to-day P&L sensitivity to regional deposit scarcity and ABS repricing to rise materially over the next 6-18 months.

Aggressive go-to-market spend in earlier-stage Mexico is buying optionality on TAM expansion but converts cash today into a multi-quarter bet on cross-sell economics; the investment makes sense only if customer ARPU and vintage retention move materially higher once credit cards season. The key second-order beneficiaries are ecosystems that monetize payments/data (processors, logistics partners, local merchants) while the near-term losers are low-margin incumbents forced to defend share through price or subsidy.

Primary tail risks are macro-driven: a regional slowdown that widens funding spreads or a regulatory clampdown on fintech lending could flip current upside into meaningful capital consumption; conversely, tighter underwriting and improved vintage performance would de-risk the balance sheet and re-rate the equity. Practical monitoring: ABS issuance yield spreads, cohort-level NPL migration at 3/6/12 months, Mexican ARPU and retention, and management commentary on funding mix and margin recovery timelines.

Key Decisions for Investors

• Directional call-spread on MELI (12-month): buy a 25–35% OTM call and sell a 60–80% OTM call to capture optionality that credit vintage/ Mexico monetization reprice the stock higher while capping premium outlay. R/R: asymmetric upside if NPL vintages normalize and ARPU inflect; max loss = paid premium, target gross return >3x if catalysts run.
• Hedge the political/funding tail with a protective put (MELI, 9–12 months): buy a single 12-month put ~20–30% OTM to limit downside from funding shock or regulatory action. R/R: small periodic insurance cost versus avoiding a multi-quarter drawdown if credit stress surfaces.
• Relative play: long NDAQ (6–12 months) to capture incremental fee pools from elevated ABS/ECM activity in LatAm, funded by selling covered calls against part of the position. R/R: expect mid-teens upside if issuance stays elevated; downside is limited to market move (~10% stress scenario) but sell calls to improve carry.
• Event hedge via credit markets: increase allocation to investment-grade LatAm ABS or buy protection on high-beta unsecured issuers if spreads widen — this is a defensive hedge to MELI equity exposure should funding-driven NIM compression accelerate. R/R: modest cost, payoff kicks in only under widening spread scenarios that would pressure equity multiples.